Comunicados de prensa U.S. FDA Salud y ciencias de la vida — Feed RSS y monitoreo en vivo
PPN World sigue el feed RSS de U.S. FDA en tiempo real — 8 comunicados indexados en los últimos 30 días, el más reciente llegó hace 4 d. Síguelo con alertas de búsquedas guardadas, resúmenes con IA y búsqueda de texto completo, o conecta la URL RSS de abajo a tu propio lector.
Sobre este feed
U.S. FDA forma parte de los más de 1,400 feeds de comunicados que PPN World monitorea de forma continua — una fuente en inglés centrada en el sector Salud y ciencias de la vida, clasificada bajo «Estados Unidos» en nuestro índice por país. Cada comunicado se deduplica, se geolocaliza y se enriquece con un resumen de IA, y puedes añadir alertas de búsquedas guardadas sobre cualquier palabra clave que publique. En los últimos 30 días, U.S. FDA ha publicado 8 comunicados, sobre todo los miércoles, con cobertura reciente centrada en fda-approval.
Sigue U.S. FDA en tiempo real en PPN World
Cada comunicado de U.S. FDA llega al cockpit segundos después de publicarse — deduplicado, clasificado, con alertas de búsquedas guardadas y resúmenes con IA, junto a más de 1,400 feeds. Prueba gratis de 72 h, sin tarjeta.
Iniciar la prueba gratis →Últimos comunicados de U.S. FDA
- FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Iahace 4 d
The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) as the first-ever treatment for adults and children 8 years of age and older…
- FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Devicehace 4 d
The U.S. Food and Drug Administration today authorized the Aletta, the first standalone robotic device that can draw blood from a patient’s arm without hands-on operator intervention.
- FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Deviceshace 5 d
The U.S. Food and Drug Administration today issued a discussion paper on considerations for the regulation of generative artificial intelligence (GenAI)-enabled medical devices, seeking feedback from…
- FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppieshace 10 d
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel chewable tablets) for the treatment of New World screwwo…
- FDA Issues Emergency Use Authorization for Drug to Prevent New World Screwworm in Multiple Species, Including Sheep, Cattle, Goats, and Swinehace 16 d
FDA today issued an Emergency Use Authorization (EUA) for CLiK Extra (dicyclanil topical suspension) wound spray for application on or around wounds for the prevention of New World screwworm (NWS) inf…
- FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanomahace 17 d
The U.S. Food and Drug Administration today granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral therapy for the treatment of advanced, ref…
- FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptomshace 18 d
The FDA approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.
- FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.hace 25 d
FDA today licensed Ezplaz Freeze Dried Plasma (FDP), making it the first freeze-dried plasma product licensed for use in the United States. Ezplaz is intended for transfusion in adult patients who nee…
- FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilothace 32 d
The U.S. Food and Drug Administration today announced the first manufacturer selected for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot.
- FDA Takes Further Steps to Remove Outdated Authorizations for Color Additives in Foodhace 32 d
The U.S. Food and Drug Administration today announced two actions targeting petroleum-based color additives in food, continuing the agency’s broader efforts to Make America Healthy Again.
- FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterolhace 37 d
The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce l…
- FDA Issues Emergency Use Authorization for Drug for Short-Term Prevention of New World Screwworm in Horseshace 39 d
The FDA today issued an Emergency Use Authorization (EUA) for Ivermectin Liquid for Horses (ivermectin oral solution) for the short-term prevention of New World screwworm (NWS) infestations (myiasis)…
Los comunicados más recientes de esta fuente se transmiten en vivo para los miembros de PPN World.
Preguntas frecuentes
¿Cómo seguir los comunicados de U.S. FDA en tiempo real?+
¿Con qué frecuencia se recogen los comunicados de U.S. FDA?+
¿Qué tipo de comunicados publica U.S. FDA?+
Feeds relacionados
- PR Newswire (US) — Health
- Newswise — Science News (US)
- U.S. CDC
- 24-7 Press Release — Industry: Biotechnology
- 24-7 Press Release — Industry: Healthcare
- 24-7 Press Release — Industry: Health & Fitness
- 24-7 Press Release — Medical: Addiction
- 24-7 Press Release — Medical: Aids
- 24-7 Press Release — Medical: Allergies
- 24-7 Press Release — Medical: Alternative Medicine